Synonyms:
SODIUM LAURIMINODIPROPIONATE; 14960-06-6; Deriphat 160 c; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; Deriphat 160 c; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395; Deriphat 160 c; Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; Deriphat 160 c; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Deriphat 160 c; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Deriphat 160 c; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; Deriphat 160 c; SODIUM LAURIMINODIPROPIONATE; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; Deriphat 160 c; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; Deriphat 160 c; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; Deriphat 160 c; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; Deriphat 160 c; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Deriphat 160 c; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; 3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; Deriphat 160 c; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; Deriphat 160 c; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; Deriphat 160 c; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; Deriphat 160 c; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; EINECS 239-032-7; Deriphat 160 c; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395; Deriphat 160 c; Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; Deriphat 160 c; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Deriphat 160 c; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Deriphat 160 c; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; Deriphat 160 c; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; Deriphat 160 c; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; Deriphat 160 c; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; Deriphat 160 c; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; Deriphat 160 c; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Deriphat 160 c; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; 3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; Deriphat 160 c; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; Deriphat 160 c; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; Deriphat 160 c; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c; SODIUM LAURIMINODIPROPIONATE; Deriphat160C; DERIPHAT 160C; Deriphat 160C; DERIPHAT 160 C; Derıphat 160 C; Deriphot 160 C; Deriphat 160; Derphat 160; 14960-06-6; UNII-7G447D0DH9; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; 7G447D0DH9; Sodium N-lauryl-beta-iminodipropionate; EINECS 239-032-7; EC 239-032-7; N-Lauryl-beta-iminodipropionic acid, sodium salt; SCHEMBL432395;Sodium N-(2-carboxyethyl)-N-dodecyl-beta-alaninate; Sodium Lauriminodipropionic Acid; CHEMBL1651997; DTXSID7041207; odium N-(2-carboxyethyl)-N-dodecyl-?-alaninate; Sodium N-(2-carboxyethyl)-N-dodecyl-ss-alaninate; N-(2-Sodiooxycarbonylethyl)-N-dodecyl-beta-alanine; Q27268223; N-(2-Carboxyethyl)-N-dodecyl-beta-alanine, monosodium salt; beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, sodium salt (1:1); 3-[(2-Carboxyéthyl)(dodécyl)amino]propanoate de sodium [French] [ACD/IUPAC Name]; Natrium-3-[(2-carboxyethyl)(dodecyl)amino]propanoat [German] [ACD/IUPAC Name]; Sodium 3-[(2-carboxyethyl)(dodecyl)amino]propanoate [ACD/IUPAC Name]; SODIUM LAURIMINODIPROPIONATE; ?-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt;3655-00-3 [RN]; EINECS 239-032-7; N-(2-Carboxyethyl)-N-dodecyl-β-alanine, monosodium salt; N-Lauryl-β-iminodipropionic acid, sodium salt; sodium 3-(2-carboxyethyl-dodecylamino)propanoate; sodium 3-(2-carboxyethyl-dodecyl-amino)propanoate; sodium 3-(2-carboxyethyl-lauryl-amino)propionate; sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate; β-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Deriphat 160 c; Beta-Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt; Beta-Alanin, N- (2-karboksietil) -N-dodesil-, monosodyum tuzu; DERIPHAT; DERIPHOT; DERİPHOT; DERPHAT; derphat; derphot; DERPHOT; derıphat; Deriphat 160c; Deriphot 160c;
TR
Deriphat 160 C is an amphoteric surfactant based on sodium N-lauryl-betaiminodipropionate.Deriphat 160 C is a clear yellowish liquid at room temperature and is prone to sedimentation at low temperatures. Deriphat 160 C should be stored indoors in a dry piace.The storage temperature should not be allowed to fall substantially below 20 °C.The congealing point of Deriphat 160 C also need to be taken into account Liquid that has solidified or that shows signs of sedimentation should be heated to 50- 70 °C and homogenized before it is processed. Please mix sufficiently prior to use.Solubility of Deriphat 160 C (10% at 23 °C) In various aqueous solutions of Deriphat 160 C, no impact on viscosity is noticeable. Deriphat 160 C is an amphoteric surfactant for cleaners. It exhibits very good foaming power in hard and soft water.Description Deriphat 160 C is a unique, multi-functional amphoteric surfactant. It can function as a foamer, cleaning agent, corrosion inhibitor, and a hydrotrope. The isoelectric point is 2.4 to 4.2.Benefits:Easy to formulate ultra concentrates Stable in strong acid and alkaline solutions Lasting corrosion inhibition Foam not effected by pH or electrolytes Effective hydrotrope Good emulsifier at low concentrations Listed on CleanGredients approved DfE Solubilizer for cationic germicides Deriphat 160 C is especially valuable for its ability to produce and maintain stable emulsions at extremes of pH. It will function effectively at highly alkaline pH where most cationic, non-ionic and anionic emulsifiers are ineffective.Product: sodium lauriminodipropionate 30% (DERIPHAT 160 C, BASF) CAS No.: 14960-06-6 Deriphat 160 C DERIPHAT 160 C is an amphoteric surfactant for cleaners which is sold as 30% liquid. The product exhibits very good foaming power in hard and soft water. Its stability over a broad pH range allows its use in acidic and alkaline formulations. DERIPHAT® 160 C can be combined with cationic surfactants which are often used as bactericides for disinfectants. DERIPHAT® 160 C is a strong hydrotrope with excellent water solubility over a broad pH range even when high electrolyte concentration is present. DERIPHAT® 160 C is compatible with other common nonionic, anionic and cationic surfactants.Value Excellent hydrotrope, providing good cleaning, wetting and corrosion inhibition.It exhibits very good foaming power in hard and soft water. 3655-00-3 (26256-79-1, 3655-00-3) Deriphat · Deriphat 160c · Deriphat 160 Cadmium is a toxic and hazardous trace metal that has become a serious environmental pollutant since industrialization and intensive farming began in late 19th century. Although there are many established wet-chemical and instrumental methods for qualitative and quantitative determination of cadmium, most involve the formation of the Cd-dithizone complex in the presence of the highly toxic potassium cyanide which is then extracted into carcinogenic chlorinated organic solvents such as chloroform or carbon tetrachloride. The main purpose of this study was to see if a sensitive, simple, quick spectro-chemical method that utilizes safer and less toxic chemicals for cadmium analysis using dithizone could be developed. The results found so far are promising and indicate that in the presence of a chelating surfactant such as Deriphat-160C, the cadmium-dithizone complex in alkaline aqueous medium remains soluble and obeys Beers law in the micro molar Cd concentration range studied. The solutions prepared for spectroscopic measurement did not require KCN nor was it necessary to extract the complex in to chlorinated organic solvents. compound in Deriphat 160C) Deriphat 160 C. 0.38% 0.38% 0.38% 24.3% In this example, Deriphat 160C® could not be dissolved in 29.6% K-glyphosate (aq.) if the concentration of Deriphat 160C was >0.38% (#1 in the table). With the addition of 0.37% C6-9 dimethylamidopropylamine, the hazy formulation became a clear solution (#2). #3 showed that pH effect is not the main reason for the dissolution of the insoluble species in K-glyphosate formulation. This concentration of surfactant in #1 was much too low to offer any benefit to glyphosate efficacy. In order for a surfactant to offer consistent benefit to glyphosate efficacy, the surfactant concentration typically has to be about greater than 7%. However, more than 24.3% Deriphat could be dissolved in the 29.6% K-glyphosate (aq.) if 2% C6-C9 dimethyamidopropylamine was added as the compatibility agent (#4).SODIUM LAURIMINODIPROPIONATE SODIUM LAURIMINODIPROPIONATE is classified as :Antistatic Cleansing Foaming Foam boosting Hair conditioning Surfactant Cosmetics Ingredients containing SODIUM LAURIMINODIPROPIONATE Sodium Lauriminodipropionate and Sodium Lauraminopropionate are sodium salts of substituted propionic acid. Sodium Lauriminodipropionate may be used in the formulation of hair conditioners, hair dyes, bath products and other cleansing products.Sodium Lauriminodipropionate functions as an anti-static agent that prevents or inhibits the build-up of static electricity.sodium lauriminodipropionate beta-alanine, N-(2-carboxyethyl)-n-dodecyl-, sodium salt (1:1)GENERIC NAME:Sodium Lauriminodipropionate 30% Lauriminodipropionic Acid, Sodium Lauriminodipropionate,and Disodium Lauriminodipropionate as Used in Cosmetics Lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate function as hair conditioning agents and surfactant-cleansing agents in cosmetic formulations. The CIR Expert Panel reviewed relevant animal and human data related to the safety of these ingredients in cosmetics. The Panel concluded that lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate are safe as cosmetic ingredients in the present practices of use and concentration.Sodium lauriminodipropionate is the sodium salt of a substituted propionic acid that is used as a surfactant,a hair conditioning agent and an antistatic agent in cosmetic formulations. In a safety assessment for sodium lauriminodipropionate and sodium lauraminopropionate published by the Cosmetic Ingredient Review (CIR) in 1997,the CIR Expert Panel concluded that the available data were insufficient to support safety of both ingredients for use in cosmetics.Additional unpublished data now are available that support the safety of sodium lauriminodipropionate as used in cosmetics. Because of chemical similarities to sodium lauriminodipropionate, the CIR Expert Panel also considered that the newly available data may be extrapolated to the parent compound, lauriminodipropionic acid,and to the disodium salt.Because no new data were available on sodium lauraminopropionate, the CIR Expert Panel did not reopen the final report to include this ingredient and reaffirmed the conclusion of insufficient data for sodium lauraminopropionate.The main impurity in the manufacture of sodium lauriminodipropionate is sodium acrylate.Trace amounts of dodecyl-chain compounds associated with the starting material, dodecylamine, may also be present. Total impurities are typically found at levels less than 2% in the product as sold. Dodecylamine, polyacrylic acid, or sodium polyacrylate have not been detected in batch samples of the commercial product. In the production of sodium lauriminodipropionate, trace levels of sodium lauraminopropionate may occur.Lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate are used as hair conditioning agents and surfactant-cleansing agents in cosmetic formulations.The monosodium and disodium salts are also used as antistatic agents and the monosodium salt is used as a surfactant-foam booster.Table 3 presents the historical and current product formulation data for sodium lauriminodipropionate.According to information supplied to the Food and Drug Administration (FDA) by industry as part of the Voluntary Cosmetic Registration Program (VCRP), sodium lauriminodipropionate was used in a total of 23 cosmetic formulations at the time of the first safety assessment.An industry survey reported use concentration range of 1-10%.1 Currently, VCRP data indicate that sodium lauriminodipropionate is used in 10 cosmetic formulations, half of which are in hair conditioners.In a survey of current use concentrations conducted by the Personal Care Products Council, sodium lauriminodipropionate is used at a concentration of 0.05% in hair conditioners.Currently, the VCRP data indicate that disodium lauriminodipropionate is used in 2 cosmetic formulations,both of which are face and neck preparations.No uses are reported for lauriminodipropionic acid.No use concentrations were reported for the acid or the disodium salt in a survey of current use concentration conducted by the.Sodium lauriminodipropionate has applications in heavy-duty alkaline cleaners, corrosion inhibitors, leather cleaners,and acid cleaners.From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.SODIUM LAURIMINODIPROPIONATE While specific information on the absorption, distribution, metabolism, and excretion of sodium lauriminodipropionate were not found, a possible metabolic scheme was described based on features of a structure activity relationship (SAR) assessment (see Scheme 1).According to the assessment, sodium lauriminodipropionate is likely to be metabolized by glucuronidation and/or N-dealkylation. Glucuronide products are known to be rapidly excreted and not likely to be biologically active. However, while this reaction is conceivable, it is rare for carboxylic acids to be glucuronidated.N-Dealkylation products are usually dietary chemicals, such as straight chain fatty acids, that undergo intermediary metabolism. (The CIR Expert Panel has concluded that lauric acid and other straight chain fatty acids and related ingredients are safe for use in cosmetic products.9-11) In this scheme, the tertiary amine group of sodium lauriminodipropionate may undergo oxidative N-dealkylation to form 3,3'-azanediyldipropanoic acid, lauric acid,and/or 3-(dodecylamino)propanoic acid. Other N-dealkylation products may be laurylamine and/or malonic acid.This reaction is nearly always catalyzed by cytochrome P450s. The mechanism involves hydrogen abstraction and hydroxylation at a carbon atom alpha to the nitrogen atom.In this scheme, sodium lauriminodipropionate may also undergo C-hydroxylation reactions on the alkyl chain. The products of this reaction may be 3,3'-(11-hydroxydodecylazanediyl)dipropanoic acid and 3,3'-(12-hydroxydodecylazanediyl)dipropanoic acid. On the longer alkyl chain, hydroxylation at the methylene group and hydroxylation at the terminal methyl group may be favorable.Dermal - Non-Human SODIUM LAURIMINODIPROPIONATE In acute dermal studies, no deaths or adverse reactions were observed in rabbits treated with 6.8 g/kg or 10.2 g/kg sodium lauriminodipropionate (10% active).From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.Oral - Non-Human SODIUM LAURIMINODIPROPIONATE The oral LD50 in albino mice treated with sodium lauriminodipropionate, 16% solids and pH 7.0, was estimated to be 17.8 ml/kg.From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.Dermal - Non-Human SODIUM LAURIMINODIPROPIONATE The percutaneous toxicity potential of sodium lauriminodipropionate was evaluated in a 91 day study in New Zealand White rabbits.12 There were 5 male and 5 female rabbits in the test group that received 2 ml/kg/day of 20% w/w solution in distilled water of 10.5% sodium lauriminodipropionate (35% of a 30% solution) in a foaming face wash. A control group of 5 male and 5 female rabbits received distilled water. The rabbits received the treatment or the control solutions daily, 5 days/week, to clipped, intact dorsal skin. The animals were checked twice daily for mortality and once daily for clinical signs of toxicity. Body weights were measured prior to study commencement, once a week during treatment, at 28 days, and at study termination. Hematology parameters were measured prior to study commencement and at study termination. All animals were killed at the end of the treatment period and underwent macro- and microscopic examination. Absolute and relative weights of the liver and kidney were determined.Dermal irritation was observed in the test group, which included slight to moderate erythema (starting on day 7), slight to moderate edema (starting on day 7), and slight to marked desquamation (days 7-14). There were no signs of systemic toxicity. All animals survived until study termination. Body weights of the treated animals were comparable to the control animals. There were no treatment-related changes to hematology parameters or differences in organ weights when compared to controls. No macroscopic or microscopic changes that suggested systemic toxicity were observed at necropsy in any of the animals. This study concluded that while sodium lauriminodipropionate did not cause dermal toxicity, it was a dermal irritant.DISODIUM LAURIMINODIPROPIONATE In a study of a hair dye formulation containing 1.5% disodium lauriminodipropionate, no systemic effects were observed in New Zealand white rabbits after topical application twice weekly for 13 weeks.SODIUM LAURIMINODIPROPIONATE While there is no information available in the literature on the reproductive and developmental toxicity of sodium lauriminodipropionate, a SAR assessment was conducted that considered the potential metabolites of this ingredient (see Figure 1).8 Sodium lauriminodipropionate is likely to be metabolized by glucuronidation and/or Ndealkylation. The specific glucuronide product for sodium lauriminodipropionate has not been assessed for reproductive or developmental toxicity, however, glucuronides in general have not been classified as developmental or reproductive hazards.Among the products of N-dealkylation, straight-chain fatty acids, such as lauric acid, have been evaluated for reproductive and developmental hazards and no adverse effects have been reported.8,14 The CIR Expert Panel has reviewed several straight-chain fatty acids, including lauric acid, and related ingredients, including plant-derived fatty acid oils, and has found these ingredients to be safe for use in cosmetic products.While the possible N-dealkylation product laurylamine has not been tested for reproductive toxicity, a similar compound, oleylamine has been assessed and found to not affect development in rats and rabbits, even at maternally toxic oral doses.The developmental NOAEL was 80 mg/kg/day for rats and 30 mg/kg/day for rabbits in these studies. Another possible N-dealkylation product, a mixture of tallow alkyl amines, did produce a decrease in offspring weight and a decrease in fertility at severely toxic levels, but this can be attributed to being secondary to the toxicity. Malonic acid may also be a product of N-dealkylation. This chemical, which has been previously assessed by the CIR Expert Panel and determined to be safe for use in cosmetic products, has been evaluated for developmental toxicity in rats.15 At concentration of 9 or 12% malonate in feed (approximate dosage for 9% malonate was 4.5 g/kg/day), low toxicity was observed in dams and fetuses.16 A few malformations were reported for 4.5 g/kg/day, but these incidences were within historical control ranges, and this dose was considered the NOAEL for developmental toxicity.Deriphat 160 C is an amphoteric surfactant based on sodium N-lauryl-betaiminodipropionate.Deriphat 160 C is a clear yellowish liquid at room temperature and is prone to sedimentation at low temperatures. Deriphat 160 C should be stored indoors in a dry piace.The storage temperature should not be allowed to fall substantially below 20 °C.The congealing point of Deriphat 160 C also need to be taken into account Liquid that has solidified or that shows signs of sedimentation should be heated to 50- 70 °C and homogenized before it is processed. Please mix sufficiently prior to use.Solubility of Deriphat 160 C (10% at 23 °C) In various aqueous solutions of Deriphat 160 C, no impact on viscosity is noticeable. Deriphat 160 C is an amphoteric surfactant for cleaners. It exhibits very good foaming power in hard and soft water.Description Deriphat 160 C is a unique, multi-functional amphoteric surfactant. It can function as a foamer, cleaning agent, corrosion inhibitor, and a hydrotrope. The isoelectric point is 2.4 to 4.2.Benefits:Easy to formulate ultra concentrates Stable in strong acid and alkaline solutions Lasting corrosion inhibition Foam not effected by pH or electrolytes Effective hydrotrope Good emulsifier at low concentrations Listed on CleanGredients approved DfE Solubilizer for cationic germicides Deriphat 160 C is especially valuable for its ability to produce and maintain stable emulsions at extremes of pH. It will function effectively at highly alkaline pH where most cationic, non-ionic and anionic emulsifiers are ineffective.Product: sodium lauriminodipropionate 30% (DERIPHAT 160 C, BASF) CAS No.: 14960-06-6 Deriphat 160 C DERIPHAT 160 C is an amphoteric surfactant for cleaners which is sold as 30% liquid. The product exhibits very good foaming power in hard and soft water. Its stability over a broad pH range allows its use in acidic and alkaline formulations. DERIPHAT® 160 C can be combined with cationic surfactants which are often used as bactericides for disinfectants. DERIPHAT® 160 C is a strong hydrotrope with excellent water solubility over a broad pH range even when high electrolyte concentration is present. DERIPHAT® 160 C is compatible with other common nonionic, anionic and cationic surfactants.Value Excellent hydrotrope, providing good cleaning, wetting and corrosion inhibition.It exhibits very good foaming power in hard and soft water. 3655-00-3 (26256-79-1, 3655-00-3) Deriphat · Deriphat 160c · Deriphat 160 Cadmium is a toxic and hazardous trace metal that has become a serious environmental pollutant since industrialization and intensive farming began in late 19th century. Although there are many established wet-chemical and instrumental methods for qualitative and quantitative determination of cadmium, most involve the formation of the Cd-dithizone complex in the presence of the highly toxic potassium cyanide which is then extracted into carcinogenic chlorinated organic solvents such as chloroform or carbon tetrachloride. The main purpose of this study was to see if a sensitive, simple, quick spectro-chemical method that utilizes safer and less toxic chemicals for cadmium analysis using dithizone could be developed. The results found so far are promising and indicate that in the presence of a chelating surfactant such as Deriphat-160C, the cadmium-dithizone complex in alkaline aqueous medium remains soluble and obeys Beers law in the micro molar Cd concentration range studied. The solutions prepared for spectroscopic measurement did not require KCN nor was it necessary to extract the complex in to chlorinated organic solvents. compound in Deriphat 160C) Deriphat 160 C. 0.38% 0.38% 0.38% 24.3% In this example, Deriphat 160C® could not be dissolved in 29.6% K-glyphosate (aq.) if the concentration of Deriphat 160C was >0.38% (#1 in the table). With the addition of 0.37% C6-9 dimethylamidopropylamine, the hazy formulation became a clear solution (#2). #3 showed that pH effect is not the main reason for the dissolution of the insoluble species in K-glyphosate formulation. This concentration of surfactant in #1 was much too low to offer any benefit to glyphosate efficacy. In order for a surfactant to offer consistent benefit to glyphosate efficacy, the surfactant concentration typically has to be about greater than 7%. However, more than 24.3% Deriphat could be dissolved in the 29.6% K-glyphosate (aq.) if 2% C6-C9 dimethyamidopropylamine was added as the compatibility agent (#4).SODIUM LAURIMINODIPROPIONATE SODIUM LAURIMINODIPROPIONATE is classified as :Antistatic Cleansing Foaming Foam boosting Hair conditioning Surfactant Cosmetics Ingredients containing SODIUM LAURIMINODIPROPIONATE Sodium Lauriminodipropionate and Sodium Lauraminopropionate are sodium salts of substituted propionic acid. Sodium Lauriminodipropionate may be used in the formulation of hair conditioners, hair dyes, bath products and other cleansing products.DISODIUM LAURIMINODIPROPIONATE In a study of a hair dye formulation containing 1.5% disodium lauriminodipropionate, no embryotoxic or teratogenic effects were observed in Charles River CD rats that were exposed to the formulation on days 1, 4, 7, 10, 13, 16, and 19 of gestation.The mutagenicity potential of 30% sodium lauriminodipropionate was assessed in an Ames test with Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and TA1538.17 The assay was performed with and without S9 metabolic activation. The concentration ranges tested were 0.003-10 μl/plate with S9 and 0.01-1.0 μl without S9. Because of lack of toxicity in test strains TA98, TA1535, and TA1538 without S9, additional assays were run using concentration ranges of 0.33-20 μl/plate. No positive responses were observed in any of the test strains, with or without S9. The vehicle control water and the positive controls 2-nitrofluorene, 2-aminoanthracene,sodium azide, and ICR-191 yielded expected results. It was concluded that sodium lauriminodipropionate was not mutagenic in this Ames test.A Chinese hamster ovary (CHO) cell assay was performed to assess the potential of 30% sodium lauriminodipropionate to induce chromosome aberrations.18 Following a range finding study, the concentration ranges for the 8 h incubation study were 0.21, 0.28, and 0.38 μl/ml without S9 and 0.48, 0.63, and 0.84 μl/ml with S9. In the 12 h incubation study, the concentration ranges were 0.28, 0.38, and 0.50 μl/ml without S9 and 0.63,0.84, and 1.13 μl/ml with S9. Relative cloning efficiency at the highest doses in the 8 h study were 34% and 70% without and with S9, respectively, while in the 12 h study, the values were 1% and 38% without and with S9, respectively. The controls, which were water, untreated cells, cyclophosphamide (CP), and triethylenemelamine (TEM), yielded expected results. The test material did not induce significant chromosome aberrations in either incubation period, with or without S9 metabolic activation. It was concluded that sodium lauriminodipropionate was not clastogenic.Sodium lauriminodipropionate, 10% solids, had a mean primary irritation index (PII) of 3.04/8 and was considered corrosive to the skin of rabbits due to eschar formation. In another study, sodium lauriminodipropionate, 16% solids at pH 7.0, was a moderate irritant to rabbit skin, with a PII of 2.17. A solution of sodium lauriminodipropionate, 10% solids, was classified as mildly irritating to the eyes of rabbits without rinsing, and practically nonirritating with rinsing. Another solution of sodium lauriminodipropionate, 16% solids at pH 7.0, was a moderate irritant.From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.No sensitization was observed in guinea pigs injected intracutaneously with 0.1% sodium lauriminodipropionate.From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.SODIUM LAURIMINODIPROPIONATE Sodium lauriminodipropionate was reported to be "practically nontoxic" to the skin and "minimally irritating" upon skin contact. It was also reported to be "minimally irritating" to the eye. Sodium lauriminodipropionate was "practically nontoxic" upon ingestion.From the Final Report on the Safety Assessment of Sodium Lauriminodipropionate.A human repeat insult patch test (HRIPT) of the potential of 2.2% sodium lauriminodipropionate (7.34% of 30% solution) to induce contact sensitization was conducted using 104 subjects.In another HRIPT, the potential of 3.5% active sodium lauriminodipropionate (11.67% of a 30% solution) to induce contact sensitization was studied in 116 subjects.2 Current FDA VCRP data indicate that sodium lauriminodipropionate is used in 10 cosmetic formulations,mainly in hair conditioners. The current concentration of use for sodium lauriminodipropionate is 0.05% in hair conditioners. Disodium lauriminodipropionate has been reported to have uses in 2 face and neck preparations. No uses are reported for lauriminodipropionic acid. No use concentrations were reported for the disodium salt or the acid.Sodium lauriminodipropionate has applications in heavy-duty alkaline cleaners, corrosion inhibitors,leather cleaners, and acid cleaners. The Environmental Protection Agency (EPA) has ruled that the sodium and potassium salts of N-alkyl (C8-C18)-beta-iminodipropionic acid do not need a maximum permissible level when they are used as inert ingredients in pesticide formulations for pre- and post-harvest applications in food crops.A possible metabolic scheme based on features of a structure activity relationship (SAR) assessment suggested that sodium lauriminodipropionate is likely to be metabolized by glucuronidation and/or N-dealkylation. In studies of 10% active solutions of sodium lauriminodipropionate, the oral LD50 for rats was 31.3 g/kg,and the dermal LD50 was greater than 10.2 g/kg; the oral LD50 for mice of a 16% solids solution was estimated as 17.8 ml/kg.A 91 day study in rabbits that received 20% w/w solution in distilled water of 10.5% sodium lauriminodipropionate (35% of a 30% solution) concluded that while sodium lauriminodipropionate did not cause dermal or systemic toxicity, it was a dermal irritant. No systemic effects were observed in rabbits that received topical applications of a hair dye formulation containing 1.5% disodium lauriminodipropionate for 13 weeks.A structure activity assessment conducted for potential metabolites of sodium lauriminodipropionate concluded that the metabolites were not developmental or reproductive toxicants. A developmental study in rats on a hair dye formulation containing 1.5% disodium lauriminodipropionate did not observe embryotoxic or teratogenic effects. Sodium lauriminodipropionate was not mutagenic in an Ames test, nor was it clastogenic in a CHO cell assay.Sodium lauriminodipropionate at 10% active solution was severely irritating to the skin of rabbits. Sodium lauriminodipropionate at 16% solids was a moderate irritant to rabbit skin.Sodium lauriminodipropionate was irritating to the eyes of rabbits. Two shampoo formulations containing 3.56% active sodium lauriminiodipropionate did not cause ocular lesions or induce a significant increase in albumin levels in tears in humans. Minimal observations of stinging or dryness sensations were made in both phases of the study.There was no evidence of sensitization to sodium lauriminodipropionate in studies with guinea pigs. A foaming face wash containing 2.2% active sodium lauriminodipropionate and a shampoo formulation containing 3.5% active sodium lauriminodipropionate did not cause delayed contact hypersensitivity in HRIPT studies.A safety assessment for sodium lauriminodipropionate and sodium lauraminopropionate was published by in 1997 with the conclusion that the available data were insufficient to support their safety in cosmetics. The Expert Panel reopened the final report on sodium lauriminodipropionate based on new data and determined that the report should also address the safety of lauriminopropionic acid and disodium lauriminodipropionate.The Panel reaffirmed the conclusion of insufficient data for sodium lauraminopropionate.The CIR Expert Panel considered that the available single dose and repeated dose animal studies, including reproductive and developmental toxicity studies, were supportive of the safety of sodium lauriminodipropionate.The Expert Panel noted the absence of carcinogenicity data, but considered that that data demonstrating that sodium lauriminodipropionate was not mutagenic or clastogenic in in vitro genotoxicity studies were adequate to support the safety of these ingredients. The Cosmetic Ingredient Review Expert Panel assessed the safety of lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate as used in cosmetics. These ingredients function in cosmetics as hair-conditioning agents and surfactant-cleansing agents. The Panel reviewed relevant animal and human data related to the safety of these ingredients in cosmetics. The Panel concluded that lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate are safe as cosmetic ingredients in the present practices of use and concentration.The Cosmetic Ingredient Review Expert Panel assessed the safety of lauriminodipropionic acid, sodium lauriminodipropionate,and disodium lauriminodipropionate as used in cosmetics. These ingredients function in cosmetics as hair-conditioning agents and surfactant-cleansing agents. The Panel reviewed relevant animal and human data related to the safety of these ingredients in cosmetics. The Panel concluded that lauriminodipropionic acid, sodium lauriminodipropionate, and disodium lauriminodipropionate are safe as cosmetic ingredients in the present practices of use and concentration.Sodium lauriminodipropionate is the sodium salt of a substituted propionic acid that is used as a surfactant, a hair-conditioning agent, and an antistatic agent in cosmetic formulations. In a safety assessment for sodium lauriminodipropionate and sodium lauraminopropionate published by the Cosmetic Ingredient Review (CIR) in 1997,1 the CIR Expert Panel concluded that the available data were insufficient to support safety of both the ingredients for use in cosmetics.Now, data that support the safety of sodium lauriminodipropionate as used in cosmetics are available. Because of thechemical similarities to sodium lauriminodipropionate, the CIRExpert Panel determined that the newly available data may beextrapolated to the parent compound, lauriminodipropionicacid, and to the disodium salt.No new safety test data were available for sodium lauraminopropionate; therefore, CIR Expert Panel did not reopen thefinal report to include this ingredient and reaffirmed the conclusion of insufficient data for sodium lauraminopropionate.Deriphat 160C is a polyfunctional surfactant for hard surface cleaners and I&I applications with excellent degreasing abilities enhancing in addition the solubility of inorganic salts and organic additives such as fragrances and cationic preservatives. Deriphat 160 is also providing corrosion inhibition and is stable under highly acidic and highly alkaline conditions. Its affinity to hard surfaces allows long lasting effects. Deriphat 160 C is especially recommended for disinfectant cleaners and cleaners for contact with metal including kitchen degreasers, bathroom cleaners and institutional cleaners.